OLF1R Olaines Kimiski - Farmaceitiska Rupnica

JSC OlainFarm appoints a new member of the Management Board of Latvijas aptieka

JSC OlainFarm appoints a new member of the Management Board of Latvijas aptieka

The Management Board of JSC OlainFarm decided to make changes in the Management Board of Latvijas aptieka Ltd. by appointing Marina Serpova, whose professional experience in business management and financial management will contribute to achieving the company's goals, as a Member of the Management Board. JSC OlainFarm is gradually improving the activities of its subsidiaries and is gradually moving towards the signing of the OlainFarm Group agreement.

The current members of the Management Board of Latvijas aptieka Ltd. will continue to perform their duties as usual with the new Management Board structure.

Marina Serpova has two degrees – technical and financial. She has 18 years of experience as a CFO, as well as in corporate and financial management in various sectors in Latvia and also abroad. Until now, Serpova has developed important skills in financial and accounting matters, team leadership and motivation. Serpova does not own any JSC OlainFarm shares.

“The goal of OlainFarm is to further strengthen the quality of our subsidiaries and move towards uniform management practices across the group. We are on the way to concluding a group agreement in order to ensure proper and joint management. Our goal is to guide the OlainFarm Group towards further sustainable development in line with modern risk management and our ambitious goals of becoming one of the TOP10 pharmaceutical companies. I highly value the OlainFarm Group's corporate team and I am convinced that the knowledge provided by a new team member is valuable for further successful development,” emphasizes Milana Beļeviča, member of the Management Board of JSC OlainFarm.

Last year 68 pharmacies were operating in 20 Latvian cities within the Latvijas aptieka Ltd. network of pharmacies owned by JSC OlainFarm. According to preliminary financial data during the entire 2019,  Latvijas aptieka sales amounted to EUR 26.1 million, demonstrating an 8% increase in comparison to 2018.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of the company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Additional information:  

Jānis Dubrovskis

Investor Relations Advisor of JSC Olainfarm

Phone:

Email:

EN
19/03/2020

Underlying

Reports on Olaines Kimiski - Farmaceitiska Rupnica

 PRESS RELEASE

Delisting of AS "Olainfarm” shares from the Baltic Main list

Delisting of AS "Olainfarm” shares from the Baltic Main list Delisting of AS "Olainfarm” shares from the Baltic Main list With this AS "Olainfarm” informs, that Nasdaq Riga decided on January 7, 2022 to approve the application of AS "Olainfarm” and to delist its shares (ISIN LV0000100501, Ticker OLF1R) from the Baltic Main List. The last listing day of AS "Olainfarm” is set to January 10, 2022. Additional information:  Jānis LeimanisJSC Olainfarm Member of the Management BoardTel. E-pasts:

 PRESS RELEASE

AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta

AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta Ar šo AS "Olainfarm” informē, ka Nasdaq Riga š.g. 7. janvārī pieņēma lēmumu apstiprināt AS "Olainfarm” akciju (ISIN LV0000100501, Biržas kods OLF1R) izslēgšanu no Baltijas Oficiālā saraksta, par pēdējo akciju kotācijas dienu nosakot 2022. gada 10. janvāri. Papildu informācija:Jānis LeimanisAS “Olainfarm” valdes loceklisTel. E-pasts:

 PRESS RELEASE

Notification about results of final buy-back of shares

Notification about results of final buy-back of shares Notification about results of final buy-back of shares Target company Joint Stock Company " Olainfarm ", registration number  40003007246, legal address: Rupnicu str. 5, Olaine, LV-2114, Latvia, phone: (+371) 67013705, e-mail:  , website: , hereinafter - Target Company.  Offeror AS “AB CITY”, registration number 40203174414, date and place of registration 11.10.2018., Rīga, legal address: Ganību dambis 24D, Riga, LV-1005, e-mail:  , website: , hereinafter - Offeror. Number of shares offered for sale A total of 549 8...

 PRESS RELEASE

Paziņojums par galīgās akciju atpirkšanas rezultātiem

Paziņojums par galīgās akciju atpirkšanas rezultātiem Paziņojums par galīgās akciju atpirkšanas rezultātiem Mērķa sabiedrība Akciju sabiedrība „Olainfarm”, reģistrācijas numurs 40003007246, juridiskā adrese: Rūpnīcu iela 5, Olaine, Olaines novads, LV-2114, tālr. (+371) 67013705; e-pasts: , mājaslapas adrese: , turpmāk – Mērķa sabiedrība. Piedāvātājs AS “AB CITY”, reģistrācijas numurs 40203174414, reģistrācijas datums un vieta 11.10.2018., Rīga, juridiskā adrese: Ganību dambis 24D, Rīga, LV-1005, e-pasts: , mājaslapas adrese: , turpmāk - Piedāvātājs. Pārdošanai p...

 PRESS RELEASE

Notification about final share buy-back

Notification about final share buy-back Joint stock company “Olainfarm”, hereinafter referred to as - “the Company”, hereby informs that by decision No. 185 of 28th December 2021, the Financial and Capital Market Commission allowed AS “AB CITY”, registration number 40203174414, to carry out the Company’s  final share buy-back. Final buy-back price is 9,26 EUR per share. The value of one share has been calculated in accordance with Section 74, Paragraphs one, Clause 3 of the Financial Instruments Market Law. The entry date is the next working day after the date of publishing the informati...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch